RE:Analyses Still PositiveExactly Smokey. Nothing has changed in the metrics or position of the company, except it's moving closer to the FDA approval. To me, this recent change in the stockprice is not at all indicative of THRM's potential. Just a play from small retail players to get lower prices; that's all.
On a turn of a dime, THRM can rise (as it did last year) from 10 cents to 1.05 within 2-3 days.
It won't take much.
Though a bummer I didn't sell at my break even zone at my DCA of 40 cents to buy back at these prices; if we all had those crystal balls wouldn't we all be enjoying the winter in some nice tropical climate?